• CK2α–VP2 Interaction Drives CIAV Replication and Pathogenesi

  2026-05-06

  This study uncovers how chicken infectious anemia virus (CIAV) co-opts the host kinase CK2α via a specific interaction with its VP2 protein, revealing a critical mechanism for viral replication and disease. The findings highlight the VP2-CK2α interface as a promising target for antiviral strategies and demonstrate the practical value of CK2 inhibition in virology research.

• HOXC8 Suppresses Pyroptosis by Regulating Caspase-1 in NSCLC

  2026-05-05

  This study reveals that HOXC8, a homeobox transcription factor, prevents pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by directly repressing caspase-1 (CASP1) expression through HDAC1/2 recruitment. These findings illuminate a non-canonical mechanism of tumor progression and suggest new targets for lung cancer research.

• Cyclopamine: Advanced Hedgehog Signaling Inhibitor Workflows

  2026-05-05

  Cyclopamine unlocks precision Hedgehog pathway inhibition across cancer and developmental models, with unique synergy in targeting APOC1-driven tumors. This guide highlights executable protocols, troubleshooting, and real-world case studies to maximize reproducibility and scientific impact.

• FCCP in Mitochondrial Biology: Applied Protocols & HIF Pathw

  2026-05-04

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) is the gold-standard mitochondrial uncoupler for dissecting oxidative phosphorylation and hypoxia signaling, with powerful applications in cancer and immunometabolic research. This article delivers advanced workflows, troubleshooting strategies, and actionable insights for maximizing FCCP’s impact in metabolic regulation studies.

• Lenalidomide (CC-5013): Optimizing Immune Modulation Workflo

  2026-05-04

  Lenalidomide (CC-5013) stands out as a multifaceted immune system activation agent and angiogenesis inhibitor, pivotal for advanced multiple myeloma research. This article translates the latest epigenetic synergy findings into actionable protocols and troubleshooting strategies for robust, reproducible results.

• Z-LEHD-FMK: Applied Workflows for Irreversible Caspase-9 Inh

  2026-05-03

  Unlock selective, irreversible caspase-9 inhibition with Z-LEHD-FMK for robust apoptosis assays and advanced neuroprotection studies. APExBIO’s reagent empowers reproducible, mitochondria-mediated apoptosis research with workflow-driven protocols and troubleshooting strategies.

• Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics

  2026-05-02

  Mdivi-1 distinguishes itself as a selective DRP1 inhibitor, enabling precise modulation of mitochondrial fission and apoptosis in both cellular and animal models. Its robust performance fuels advanced mitochondrial dynamics research, neuroprotection studies, and apoptosis assays with reproducible and interpretable results.

• 10074-G5 (SKU C5722): Reliable c-Myc Inhibitor for Cancer Re

  2026-05-01

  This article addresses key laboratory scenarios encountered when deploying 10074-G5 (SKU C5722) as a c-Myc inhibitor in cell viability, proliferation, and cytotoxicity assays. Focusing on workflow reproducibility and validated performance, it offers evidence-backed insights for optimizing apoptosis, cell cycle arrest, and tumor regression studies using 10074-G5.

• Lipid Scrambling and Ferroptosis: TMEM16F as a Key Regulator

  2026-05-01

  Yang et al. (2025) uncover TMEM16F's pivotal role as a plasma membrane lipid scramblase that suppresses ferroptosis by orchestrating phospholipid redistribution during oxidative damage. Disruption of TMEM16F-mediated scrambling sensitizes cells to ferroptosis and enhances anti-tumor immunity, offering a new mechanistic window into late-stage cell death regulation and potential cancer immunotherapy strategies.

• Novobiocin Inhibits Membrane and Vacuole Formation in E. fae

  2026-04-30

  This study demonstrates that Novobiocin Sodium, an aminocoumarin antibiotic, inhibits both membrane synthesis and vacuole formation in Enterococcus faecalis protoplasts by blocking DNA replication. The findings provide mechanistic insight into the coupling between DNA replication and membrane morphogenesis, with implications for cell cycle and antibiotic resistance research.

• FCCP in Immunometabolism: Uncoupling Mitochondria to Advance

  2026-04-30

  Explore how FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) enables advanced mitochondrial biology and immunometabolic research. This article uniquely connects FCCP’s uncoupling mechanism to recent breakthroughs in tumor microenvironment studies.

• Reversine: Aurora Kinase Inhibitor Workflows for Cancer Rese

  2026-04-29

  Reversine is a potent Aurora kinase inhibitor that empowers advanced cancer biology and developmental assays with precision and reproducibility. By integrating large-scale gastruloid modeling, robust apoptosis induction, and tailored protocol parameters, researchers can tackle challenging questions in mitotic regulation and tumor proliferation. Discover optimized workflows, troubleshooting strategies, and evidence-driven guidance for maximizing your experimental impact.

• Lenalidomide (CC-5013): Mechanistic Innovation & Translation

  2026-04-29

  This thought-leadership article integrates cutting-edge mechanistic insights and strategic experimental guidance for translational researchers exploring Lenalidomide (CC-5013). Building on recent epigenetic findings and workflow innovations in multiple myeloma, it highlights actionable protocols, competitive context, and the future landscape of immunomodulatory research, with a special emphasis on APExBIO’s product leadership.

• One-step TUNEL FITC Apoptosis Detection Kit: Applied Workflo

  2026-04-28

  The One-step TUNEL FITC Apoptosis Detection Kit streamlines apoptosis detection across both tissue sections and cultured cells, enabling precise quantification of DNA fragmentation. Its robust FITC-labeled dUTP incorporation facilitates high-sensitivity analysis for cancer, neuroinflammation, and immunology workflows where workflow reliability and troubleshooting support are critical.

• Procainamide Hydrochloride: Integrating Cardiac and Epigenet

  2026-04-28

  This thought-leadership article explores how Procainamide Hydrochloride, a classic cardiac sodium channel blocker, is transforming translational research by bridging electrophysiology and epigenetics. Drawing on mechanistic and translational evidence, including recent liposomal co-delivery studies, it offers actionable strategies for researchers in cardiac and oncology domains.

7098 records 17/474 page Previous Next First page 上5页 1617181920 下5页 Last page